Is Alpha Lipoic Acid Blood Glucose Randomized Trial safe?

Updated July 2026

Quick Answer

Alpha Lipoic Acid Blood Glucose Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Experimental data and clinical studies highlight the cardiometabolic changes associated with gonadal aging and reproductive hormones’ withdrawal [].

Key Takeaways

  • 01Experimental data and clinical studies highlight the cardiometabolic changes associated with gonadal aging and reproductive hormones’ withdrawal []. [Karaflou Maria (2026)]
  • 02Body composition changes with increased fat mass and abdominal fat distribution are associated with insulin resistance and subsequent diabetes in older ages [,]. [Karaflou Maria (2026)]
  • 035 6 7 Oxidative stress is closely associated with conditions that predispose individuals to T2DM, including obesity. [Karaflou Maria (2026)]
  • 041 1 2 www.pubmed.gov Menopause and male late-onset hypogonadism (LOH) are well-described transitions in females and males during their lifespan. [Karaflou Maria (2026)]
The current Migaku evidence database contains 2 reusable source documents for Alpha Lipoic Acid Blood Glucose Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Experimental data and clinical studies highlight the cardiometabolic changes associated with gonadal aging and reproductive hormones’ withdrawal []. [Karaflou Maria (2026); evidence level 3] - Body composition changes with increased fat mass and abdominal fat distribution are associated with insulin resistance and subsequent diabetes in older ages [,]. [Karaflou Maria (2026); evidence level 3] - 5 6 7 Oxidative stress is closely associated with conditions that predispose individuals to T2DM, including obesity. [Karaflou Maria (2026); evidence level 3] - 1 1 2 www.pubmed.gov Menopause and male late-onset hypogonadism (LOH) are well-described transitions in females and males during their lifespan. [Karaflou Maria (2026); evidence level 3] - This review critically evaluates the mechanistic rationale and clinical evidence for alpha-lipoic acid (ALA) and benfotiamine as adjunctive treatments for DPN. [Ciubotaru A (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Antioxidants in Menopausal Transition and Male Late-Onset Hypogonadism for the Prevention of Diabetes
  2. Alpha-Lipoic Acid and Benfotiamine in Diabetic Peripheral Neuropathy: A Critical Review of Mechanistic Rationale and Clinical Evidence Within a Nutritional Therapeutic Framework.